Verified peer comparison
BlackRock TCP Capital vs CytomX Therapeutics Financial Comparison
Direct answer
BlackRock TCP Capital and CytomX Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free BlackRock TCP Capital email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- BlackRock TCP Capital Revenue
- -76,346,573 USD
- CytomX Therapeutics Revenue
- 76,201,000 USD
- BlackRock TCP Capital Operating income
- -22,839,866 USD
- CytomX Therapeutics Operating income
- -22,364,000 USD